Skip to main content

Table 1 Profiles of the patients studied

From: Association of cerebrospinal fluid anti-ribosomal P protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus

Diagnosis Number of patients Gender (male/female) Age in years (mean ± SD)
SLE 103   
Diffuse NP-SLE 52 4/48 37.8 ± 14.2
   Acute confusional state 20   
   Anxiety disorder 3   
   Cognitive dysfunction 10a   
   Mood disorder 12b   
   Psychosis 7   
Focal NP-SLE 19 2/17 39.0 ± 14.8
   Cerebrovascular disease 6   
   Headache 2   
   Movement disorder 1   
   Seizure disorder 6   
   Polyneuropathy 4   
Non-CNS SLE 32 3/29 42.7 ± 13.9
Non-SLE control 24 22/2 48.0 ± 13.7
  1. aOne patient also presented mood disorder. bOne patient also presented cognitive dysfunction. Non-CNS SLE, systemic lupus erythematosus without neuropsychiatric manifestations; NP-SLE, neuropsychiatric systemic lupus erythematosus; SD, standard deviation; SLE, systemic lupus erythematosus.